相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples
David Casadevall et al.
CLINICAL LUNG CANCER (2017)
Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma
A. Strati et al.
ANNALS OF ONCOLOGY (2017)
PD-L1 expressing circulating tumour cells in head and neck cancers
Arutha Kulasinghe et al.
BMC CANCER (2017)
Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors
Z. Cierna et al.
ANNALS OF ONCOLOGY (2016)
Method for semi-automated microscopy of filtration-enriched circulating tumor cells
Emma Pailler et al.
BMC CANCER (2016)
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
Archana Anantharaman et al.
BMC CANCER (2016)
Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs)
Galatea Kallergi et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
CTC immune escape mediated by PD-L1
Xuefei Wang et al.
MEDICAL HYPOTHESES (2016)
High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1
Jennifer L. Schehr et al.
PLOS ONE (2016)
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
Chiara Nicolazzo et al.
SCIENTIFIC REPORTS (2016)
High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non- small- cell lung cancer
E. Pailler et al.
ANNALS OF ONCOLOGY (2015)
Frequent expression of PD-L1 on circulating breast cancer cells
Martine Mazel et al.
MOLECULAR ONCOLOGY (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs
Yanna Tang et al.
ONCOTARGET (2015)
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
A. D'Incecco et al.
BRITISH JOURNAL OF CANCER (2015)
Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer
Sofia Agelaki et al.
PLOS ONE (2015)
High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
Yueh-Min Lin et al.
PLOS ONE (2015)
Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2015)
Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
Maria A. Papadaki et al.
BMC CANCER (2014)
Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib
Antonia Kalykaki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer
N. Xenidis et al.
BRITISH JOURNAL OF CANCER (2013)
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study
V. Georgoulias et al.
ANNALS OF ONCOLOGY (2012)
Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method
V. Hofman et al.
CYTOPATHOLOGY (2012)
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
Matthew G. Krebs et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
F. Farace et al.
BRITISH JOURNAL OF CANCER (2011)
Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method
Veronique Hofman et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2011)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Systemic spread is an early step in breast cancer
Yves Huesemann et al.
CANCER CELL (2008)
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer
Michail Ignatiadis et al.
CLINICAL CANCER RESEARCH (2008)
Circulating tumor cells and bone marrow micrometastasis
Catherine Alix-Panabieres et al.
CLINICAL CANCER RESEARCH (2008)
Cancer - The metastasis cascade
Christoph A. Klein
SCIENCE (2008)
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath et al.
NATURE (2007)
Metastasis: recent discoveries and novel treatment strategies
Suzanne A. Eccles et al.
LANCET (2007)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Circulating tumor cells in patients with breast cancer dormancy
SD Meng et al.
CLINICAL CANCER RESEARCH (2004)
Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma
S Kummar et al.
BRITISH JOURNAL OF CANCER (2002)
分享论文
